All lobbying filings
S-3 GROUP
Lobbying for ALKERMES, INC. · Global biopharmaceutical company specializing in innovative treatments
Filing
1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
4
-
JOHN SCOFIELDPreviously held: Comm Dir, House Approps, Press Sec., Rep LoBiondo
-
MARTIN DELGADOPreviously held: Staff Dir, House Ag Approps, Prof Staff, Milcon/VA Approps
-
OLIVIA KURTZPreviously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle
-
ASHLEY DAVIS New on this filingPreviously held: Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President
Government bodies contacted
2
Lobbying activity
1
Issues related to legislation and policies that support treatment for alcohol and opioid dependency at SAMSHA, VA and DOJ